Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of Moderate Buy by Brokerages

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) have received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […]

Related Keywords

New York ,United States ,Jamesr Swartz ,Sutro Biopharma ,Wells Fargo Company ,York State Common Retirement Fund ,Sutro Biopharma Company Profile ,Sutro Biopharma Inc ,Jump Financial ,Nasdaq ,Allspring Global Investments Holdings ,Get Rating ,Biopharma Inc ,Sutanto Widjaja ,South San Francisco ,Sutro Biopharma Daily ,Nasdaq Stro ,Castro ,Medical ,Ratings ,Consensus ,